Literature DB >> 11308137

Behçet disease.

L A Lee1.   

Abstract

Behçet's disease is a multisystem inflammatory disorder of unknown origin, characterized by recurrent oral and genital ulcerations, ocular and cutaneous lesions, arthritis, central nervous system, and vascular disease. There is no pathognomonic laboratory test, but there are clinical criteria to assist in establishing the diagnosis. Behçet's is most common along the Silk Road. It is particularly common among persons who have the HLA-B51 major histocompatibility type. Cutaneous lesions include pustules, erythema nodosum-like lesions, Sweet's-like lesions, pyoderma gangrenosum-ike lesions, and pathergy. The major cutaneous findings may be classified as neutrophilic vascular reactions. There is considerable morbidity resulting from Behçet's disease, most notably a high risk of blindness from ocular involvement. Mortality may occur as a result of neurologic or vascular disease or gastrointestinal perforation.

Entities:  

Mesh:

Year:  2001        PMID: 11308137     DOI: 10.1053/sder.2001.23097

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  4 in total

1.  Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behçet's syndrome.

Authors:  Yusuf Turkoz; Cem Evereklioglu; Abdullah Ozkiriş; Selçuk Mistik; Murat Borlu; Ibrahim H Ozerol; Fuat Duygulu; Ozgür Ilhan
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

2.  Clinical Significance of Serum Bilirubin in Behçet's Disease.

Authors:  Tuba Tülay Koca
Journal:  J Transl Int Med       Date:  2018-12-31

3.  Etiology of Uveitis in Upper Egypt.

Authors:  Eiman Abd El Latif; Asaad Nooreldin; Mohammed Shikhoun Ahmed; Mohamed Elmoddather; Wael El Gendy
Journal:  Clin Ophthalmol       Date:  2021-01-18

Review 4.  Breaking the Magic: Mouth and Genital Ulcers with Inflamed Cartilage Syndrome.

Authors:  Stella Pak; Shaina Logemann; Christine Dee; Adam Fershko
Journal:  Cureus       Date:  2017-10-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.